期刊文献+

口服大剂量甲基泼尼松龙治疗婴儿痉挛症的疗效观察 被引量:1

Efficacy observation of high dose oral methylprednisolone in the treatment of infantile spasms
分享 导出
摘要 目的探讨口服大剂量甲基泼尼松龙治疗婴儿痉挛症(IS)的临床疗效和安全性。方法回顾性分析2016年1月至2017年4月华中科技大学同济医学院附属武汉儿童医院神经内科接受口服大剂量甲基泼尼松龙治疗的38例婴儿痉挛患儿临床资料。结果(1)38例患儿治疗2周时痉挛发作完全控制20例(52.6%);疗程结束时痉挛发作完全控制16例(42.1%)。(2)38例均有典型或不典型高度失律,治疗2周时有25例(65.8%)高度失律消失;疗程结束时有30例(78.9%)高度失律消失。(3)不良反应主要有体重增加、库欣体征、食欲增加、易激惹、嗜睡、合并感染、电解质紊乱。停用药物后不良反应逐渐消失。(4)随访3~12个月,复发率低,发育商均有改善。结论口服大剂量甲基泼尼松龙治疗IS具有较好的疗效,且较安全,复发率低,可在临床上推广应用。 Objective To investigate the clinical efficacy and safety of oral high-dose methylpred- nisolone in the treatment of infantile spasms (IS). Methods The clinical data of 38 children with infantile spasms were analyzed retrospectively who treated with oral administration of high-dose methylprednisone in Department of Neurology, Wuhan Children~ Hospital, Tongji Medical College, Huazhong University of Science and Technology from January 2016 to April 2017. Results (1) Twenty patients (52. 6% ) of all the 38 patients were seizure-free after 2 weeks of treatment, and 16 cases (42. 1% ) were seizure-free at the end of treatment. (2) All the 38 cases were typical or atypical hyperarrhythmia. After treatment of 2 weeks, 25 cases (65.8%) of hyperarrhythmia disappeared; at the end of the treatment, 30 cases (78. 9% ) of hyperar-rhythmia disappeared. (3) Adverse effects mainly were weight gain, Cushing signs, increased appetite, irri- tability, drowsiness, co-infection, electrolyte disturbance. (4) Follow-up of 3 to 12 months, the recurrence rate was low and the development quotient had improved. Conclusions Oral high dose methylprednisolone in the treatment of IS is effective, safe and has a low recurrence rate. It can be recommended in clinicalal application.
作者 朱红敏 孙丹 陈雪 胡家胜 吴革菲 吴舒华 刘智胜 Zhu Hongmin, Sun Dan, Chen Xue, Hu Jiasheng, Wu Gefei, Wu Shuhua, Liu Zhisheng (Department of Neurology, Wuhan Children's Hospital, Tongfi Medical College, Huazhong University of Science & Technology, Wuhan 430016, China)
出处 《中国医师杂志》 CAS 2017年第8期1130-1133,1138共5页 Journal of Chinese Physician
基金 武汉市科技创新平台-儿童神经疾病临床医学研究中心资助项目(武科计2014-160号) 武汉黄鹤英才(医疗卫生)计划专项经费资助项目(武人才办2014-10号)
关键词 泼尼松龙/投药和剂量 痉挛 婴儿/药物疗法 投药 口服 Prednisolone/AD Spasms, infantile/DT Administration, oral
作者简介 通信作者:刘智胜,Email:liuzsc@126.com
  • 相关文献

参考文献5

二级参考文献63

  • 1陈国利,张月华,秦炯,陈小荣,刘晓燕,包新华,姜玉武,吴晔,王爽,吴希如.促肾上腺皮质激素治疗婴儿痉挛的疗效及其影响因素[J].中国实用儿科杂志,2004,19(7):406-408. 被引量:2
  • 2王艺,陈雯,邱鹏玲,孙道开.婴儿痉挛临床诊治与预后127例分析[J].中国实用儿科杂志,2006,21(3):191-193. 被引量:15
  • 3黄少武,李俊华.30例婴儿痉挛症临床分析[J].中国医师进修杂志:内科版,2007,30(3):64-64. 被引量:1
  • 4胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636. 被引量:2065
  • 5左启华.小儿神经系统疾病[M].2版.北京:人民卫生出版社,2002:936-938. 被引量:102
  • 6Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multi?centre, randomised controlled trial[J]. Lancet, 2004,364 (9447):1773-1778. 被引量:1
  • 7Kossoff EH, Hartman AL, RubensteinJE, et al. High?dose oral prednisolone for infantile spasms: an effective and less expensive alternative to ACTH[J]. Epilepsy Be- hav,2009,14(4) :674-676. 被引量:1
  • 8Lux AL, OsborneJP. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group[J]. Epilepsia,2004,450l) :1416-1428. 被引量:1
  • 9Mohamed BP,Scott RC,Desai N;et al. Seizure outcome in infantile spasms-a retrospective study[J]. Epilepsia , 2011 , 52(4) :746-752. 被引量:1
  • 10PellockJ M, Hrachovy R, Shinnar S, et al. Infantile spasms: a U. S. consensus report]]"]. Epilepsia , 2010,51(0) : 2175- 2189. 被引量:1

共引文献21

同被引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈